Am J Physiol Cell Physiol Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol (January 22, 2003). doi:10.1152/ajpcell.00466.2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/6/C1374    most recent
00466.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McGinn, S.
Right arrow Articles by Pollock, C. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McGinn, S.
Right arrow Articles by Pollock, C. A
Submitted on October 3, 2002
Accepted on January 11, 2003

High glucose and endothelial cell growth: Novel effects independent of autocrine TGF{beta}1 and hyperosmolarity

Stella McGinn1, Philip Poronnik2, Malcolm King3, Eileen D Gallery1, and Carol A Pollock1*

1 Department of Medicine, Kolling Institute, Royal North Shore Hospital, Sydney, NSW, Australia
2 Department of Medicine, Kolling Institute, Royal North Shore Hospital, Sydney, NSW, Australia; Department of Physiology, University of Sydney, Sydney, NSW, Australia
3 Department of Immunology, Royal North Shore Hospital, Sydney, NSW, Australia

* To whom correspondence should be addressed. E-mail: carpol{at}med.usyd.edu.au.

Methods. Human endothelial cells were exposed to 5mM glucose (control), 25mM (high) glucose or osmotic control for 72 hours. TGF{beta}1 production, cell growth, death and cell cycle progression and the effects of TGF{beta}1 and TGF{beta} neutralisation on these parameters were studied. Results. High glucose and hyperosmolarity increased endothelial TGF{beta}1 secretion (P<0.0001) and bioactivity (P<0.0001). However high glucose had a greater effect on reducing endothelial cell number (P<0.001) and increasing cellular protein content (P < 0.001) than the osmotic control. TGF{beta} antibody only reversed high glucose's antiproliferative and hypertrophic effects. High glucose altered cell cycle progression and cyclin dependent kinase inhibitor (cdki) expression independent of hyperosmolarity. High glucose increased endothelial cell apoptosis (P < 0.01) while hyperosmolarity induced endothelial cell necrosis (P < 0.001). TGF{beta} antibody did not reverse the apoptotic effects observed with high glucose. Exogenous TGF{beta}1 mimicked the increased S phase delay but not endoreduplication observed with high glucose. Conclusion. High glucose altered endothelial cell growth, apoptosis and cell cycle progression. These growth effects occurred principally via a TGF{beta}1 autocrine pathway. In contrast, apoptosis and endoreduplication occurred independent of this cytokine and hyperosmolarity.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Varma, B. K. Lal, R. Zheng, J. W. Breslin, S. Saito, P. J. Pappas, R. W. Hobson II, and W. N. Duran
Hyperglycemia alters PI3k and Akt signaling and leads to endothelial cell proliferative dysfunction
Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1744 - H1751.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. McGinn, S. Saad, P. Poronnik, and C. A. Pollock
High glucose-mediated effects on endothelial cell proliferation occur via p38 MAP kinase
Am J Physiol Endocrinol Metab, October 1, 2003; 285(4): E708 - E717.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1976 by the American Physiological Society.